• Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=8412323).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro177Leu (c.530C>T); ClinVar=VCV000406583; Zygosity=Unspecified (PubMed=7727782; PubMed=8412323).
  

PubMed=8372807; DOI=10.1002/ajh.2830430404
Sotomatsu M., Yugami S.-i., Shitara T., Kuroume T.
Dipyridamole enhancement of drug sensitivity in acute lymphoblastic leukemia cells.
Am. J. Hematol. 43:251-255(1993)

PubMed=8412323
Sotomatsu M., Hayashi Y., Kawamura M., Yugami S.-i., Shitara T.
Establishment of a new human pre-B acute lymphoblastic leukemia cell line (KMO-90) with 1;19 translocation carrying p53 gene alterations.
Leukemia 7:1615-1620(1993)

PubMed=7727782; DOI=10.1182/blood.V85.9.2546.bloodjournal8592546
Kawamura M., Kikuchi A., Kobayashi S., Hanada R., Yamamoto K., Horibe K., Shikano T., Ueda K., Hayashi K., Sekiya T., Hayashi Y.
Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
Blood 85:2546-2552(1995)

PubMed=10637496; DOI=10.1038/sj.leu.2401604
Drexler H.G., Fombonne S., Matsuo Y., Hu Z.-B., Hamaguchi H., Uphoff C.C.
p53 alterations in human leukemia-lymphoma cell lines: in vitro artifact or prerequisite for cell immortalization?
Leukemia 14:198-206(2000)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)